An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Conditions

• Recurrent B-Cell Non-Hodgkin Lymphoma
• Recurrent Follicular Lymphoma
• Recurrent Indolent Adult Non-Hodgkin Lymphoma
• Recurrent Marginal Zone Lymphoma
• Refractory B-Cell Non-Hodgkin Lymphoma
• Refractory Follicular Lymphoma
• Refractory Indolent Adult Non-Hodgkin Lymphoma
• Refractory Marginal Zone Lymphoma

Interventions

• DRUG: Venetoclax
• DRUG: Lenalidomide
• BIOLOGICAL: Rituximab
• BIOLOGICAL: Rituximab and Hyaluronidase Human

Sponsor

Thomas Jefferson University

Collaborators

• [object Object]